Moderna on Thursday said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine ...
Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...
Moderna Inc Chief Executive Officer Stéphane Bancel expects interim results from its COVID-19 vaccine trial in November and that the U.S government could give an emergency use nod in December, the ...
“The opening of the Moderna Innovation and Technology Centre marks the first facility in the UK to manufacture an onshore supply of mRNA vaccines,” said Stéphane Bancel, Chief Executive Officer of ...
Hosted on MSN
Moderna Cuts 10% of Its Staff as Cash Hoard Dwindles
Moderna told employees Thursday morning that it plans to cut 10% of its workforce, a significant blow for a company that became the best-known biotech in the world during the Covid-19 pandemic. The ...
Moderna seeks emergency use authorization for Covid-19 vaccine for children ages 6 months to 5 years
NEW YORK -- Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback